Pfizer Inc. (NYSE: PFE) today announced that it has signed licensing agreements with AbbVie (Nasdaq: ABBV) , resolving all global ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE